AgaMatrix, Inc., a privately held developer and manufacturer of blood glucose monitoring products, has received clearance from the Unites State Food and Drug Administration to sell its Zero-Click(TM) Blood Glucose Data Management System. Zero-Click makes it easier for users to download and manage data from AgaMatrix's blood glucose monitoring systems.  Go to Medical News Today article

Key Players engaged in developing biosensor technology include AgaMatrix, Inc. Go to press release

^{AgaMatrix Presto builds on the existing base of WaveSense customers that is expected to exceed 1,000,000 by this fall. Go to press release}

Renewable energy is a hot topic these days, given soaring gasoline prices and discussions of how production of ethanol, now primarily a home-grown, cornstarch product, can be boosted to reduce the nation's reliance on imported oil. Go to Boston Globe article

Codon Devices, Inc., the Constructive Biology^TM Company, announced today that it has achieved the first development milestone in its collaboration with Agrivida, Inc. Go to press release

Agrivida, Inc. (MA) - up to $982,589. Grant Purpose: To study altered plant compositions for improved biofuel production. This will include analysis of rice straw, sorghum, and switchgrass performance in specific U.S. regions. Go to press release

With big plans for a European expansion, a New Hampshire maker of blood glucose-monitoring products has snatched a major round of private equity financing. Go to Mass High Tech article

Today, Agrivida Inc., announced that it has entered into an agreement with Codon Devices Inc. for the discovery, development, and commercialization of engineered proteins for use in biofuel applications. Go to press release

AgaMatrix, developers of WaveSense, a suite of patented patented technologies that enable high accuracy blood glucose monitoring products, announced today that a number of leading diabetes educators have joined their Diabetes Educators Board. Go to press release

AgaMatrix, Inc., a privately held developer and manufacturer of blood glucose monitoring products, has received clearance from the United States Food and Drug Administration to sell its Zero-Click™ Blood Glucose Data Management System.  Zero-Click makes it easier for users to download and manage data from AgaMatrix's blood glucose monitoring systems. Go to press release